Empowered Funds LLC bought a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 576,918 shares of the company’s stock, valued at approximately $74,134,000.
Other hedge funds also recently made changes to their positions in the company. Gables Capital Management Inc. purchased a new stake in Merck KGaA during the second quarter valued at $2,095,000. Diversify Advisory Services LLC purchased a new stake in Merck KGaA during the 2nd quarter valued at $3,810,000. Danske Bank A S bought a new stake in Merck KGaA in the second quarter worth $276,535,000. Danica Pension Livsforsikringsaktieselskab bought a new stake in Merck KGaA in the second quarter worth $25,541,000. Finally, BOK Financial Private Wealth Inc. purchased a new position in Merck KGaA during the second quarter worth $523,000. 0.10% of the stock is currently owned by hedge funds and other institutional investors.
Merck KGaA Stock Down 3.9%
Shares of OTCMKTS MKGAF opened at $158.15 on Friday. The company has a market cap of $20.44 billion, a P/E ratio of 24.14 and a beta of 0.96. The firm has a 50-day simple moving average of $163.21 and a two-hundred day simple moving average of $148.95. Merck KGaA has a 1 year low of $116.68 and a 1 year high of $175.56. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
See Also
- Five stocks we like better than Merck KGaA
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
